Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Mar 20, 2019	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0000320017-19-000032.pdf 0000320017-19-000032.rtf 0000320017-19-000032.xls
Mar 19, 2019	10-K/A	Amendment to a previously filed 10-K	View HTML 0000320017-19-000027.pdf 0000320017-19-000027.rtf 0000320017-19-000027.xls
Mar 14, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-19-000020.pdf 0000320017-19-000020.rtf 0000320017-19-000020.xls
Mar 14, 2019	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0000320017-19-000022.pdf 0000320017-19-000022.rtf 0000320017-19-000022.xls
Mar 14, 2019	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000320017-19-000024.pdf 0000320017-19-000024.rtf 0000320017-19-000024.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 13, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-19-000008.pdf 0000320017-19-000008.rtf 0000320017-19-000008.xls
Jan 22, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-19-000004.pdf 0000320017-19-000004.rtf 0000320017-19-000004.xls
Jan 16, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001373585-19-000013.pdf 0001373585-19-000013.rtf 0001373585-19-000013.xls
Jan 16, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001192621-19-000013.pdf 0001192621-19-000013.rtf 0001192621-19-000013.xls
Jan 16, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001078274-19-000009.pdf 0001078274-19-000009.rtf 0001078274-19-000009.xls